The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENGOT-ov54/Swiss-GO-2/MATAO including LOGOS (Low-Grade Ovarian cancer Sub-study): MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer—A randomized, double-blinded, placebo-controlled, multicenter phase III Trial.
 
Viola A. Heinzelmann-Schwarz
No Relationships to Disclose
 
Christian Kurzeder
Honoraria - AstraZeneca (Inst); AstraZeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); PharmaMar (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Genomic Health (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Expert Testimony - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Seraina Schmid
No Relationships to Disclose
 
Natalie Gabriel
No Relationships to Disclose
 
Andreas Mueller
Stock and Other Ownership Interests - Vifor Pharma
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Genomic Health; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Tesaro
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Pfizer; Roche; Tesaro
 
Mathias Konrad Fehr
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - PharmaMar
 
Christian Marth
Honoraria - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche
 
Andreas Du Bois
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; Genmab; GlaxoSmithKline/Tesaro; Ingress Health; Roche/Genentech; TLC Biopharmaceuticals
 
Maximillian Klar
Expert Testimony - AstraZeneca; KLS Martin; Roche
Travel, Accommodations, Expenses - Intuitive Surgical